Mediwound (MDWD) Stock Statistics & Valuation Metrics

Mediwound has a market cap or net worth of $221.66M. The enterprise value is $137.83M.

Mediwound has 12,835,186 shares outstanding. The number of shares has decreased by -2.65% in one year.

Mediwound’s return on equity (ROE) is -0.97 and return on invested capital (ROIC) is -40.92%.

The current PE Ratio of Mediwound is ―. Mediwound’s PEG ratio is -0.02.

In the last 12 months, Mediwound had revenue of 20.22M and earned -30.22M in profits. Earnings per share was -3.03.

In the last 12 months, operating cash flow was -14.10M and capital expenditures -3.92M, giving a free cash flow of -18.02M billion.

Mediwound pays an annual dividend of ―, resulting in a dividend yield of ―

Mediwound upcoming earnings date is Mar 12, 2026, Before Open (Confirmed).

Mediwound as a current ratio of 1.97, with Debt / Equity ratio of 18.60%

In the past 12 months, Mediwound has paid 61.00K in taxes.

Mediwound EV to EBITDA ratio is -6.23, with an EV/FCF ratio of -8.80.

Mediwound has $59.09M in cash and marketable securities with $9.33M in debt, giving a net cash position of $49.76M billion.

Gross margin is 18.53%, with operating margin of -95.85%, and net profit margin of -149.46%.

The average price target for Mediwound is $31.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy